Hyderabad, India -- (SBWIRE) -- 02/27/2018 -- ECMO machine treatment is employed most in patients affected by internal organ failure or cardiogenic shock followed by patients corresponding to metabolic process failure. This treatment option is also used for patients undergoing a heart transplant or a respiratory organ transplant. According to the information recorded by the American research studies, in 2013, Chronic Obstructive Pulmonary Disease (COPD) was recorded to be the third largest reason behind death across the United States. Additionally, over 24.0 million people are estimated to remain undiagnosed within the U.S. and 11.0 million diagnosed for COPD.

View sample and decide: https://www.marketdataforecast.com/market-reports/extracorporeal-membrane-oxygenation-machine-market-4977/request-sample

The global Extracorporeal Membrane Oxygenation Machine market is estimated to have a value of USD 247.2 million in 2016. With a CAGR of 4.3%, the market size is expected to grow rapidly to cross USD 305.12 million by 2021. The market growth apart from rising incidences of chronic diseases can be attributed to the increased health facilities with ECMO machines and rising tobacco consumption among both genders resulting in pulmonary diseases.

To know more read: https://www.marketdataforecast.com/market-reports/extracorporeal-membrane-oxygenation-machine-market-4977/

The augmented use of ECMO machines in Veno-Venous (VV) category diseases has led to their significant market share among ECMO machine market products. The growth in this segment is due to factors such as high incidences of respiratory failure, rise in lung transplants, and technological advancements. Depending on the application, the highest share by volume of the market is contributed by respiratory segment. This is due to the rising incidences of respiratory failure due to increased consumption of nicotine rich products.

The ECMO systems are accustomed to treating severe internal organ conditions such as cardiac shock or arrest in which the ECMO machine serves as a synthetic heart. According to the report published recently in January 2016, there were overall 22,140 patients globally who suffered from cardiac illness and required ECMO. More than 8.7 million individuals are affected by chronic bronchitis and 3.4 million individuals are suffering from emphysema in the year 2014 resulting in the need for ECMO facilitated centers globally.

Get your customized report: https://www.marketdataforecast.com/market-reports/extracorporeal-membrane-oxygenation-machine-market-4977/customize-report

As of now, North America with its advanced cutting-edge technologies and increased healthcare expenditure for individuals accounts for the largest share of global Extracorporeal Membrane Oxygenation Machine market, followed by Europe and the Asia Pacific.

The major market contributors for the global Extracorporeal Membrane Oxygenation Machine market are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc. and EUROSETS S.r.l.

The scope of the report provides:
The evaluation of the current market for your product or services and the future implications of the market
Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter's Five Forces
The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
Equip you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626